Kirin (OTCMKTS:KNBWY) & Arcadia Biosciences (NASDAQ:RKDA) Financial Analysis

Kirin (OTCMKTS:KNBWY) and Arcadia Biosciences (NASDAQ:RKDA) are both consumer staples companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

Risk and Volatility

Kirin has a beta of -0.01, indicating that its share price is 101% less volatile than the S&P 500. Comparatively, Arcadia Biosciences has a beta of 0.53, indicating that its share price is 47% less volatile than the S&P 500.

Insider and Institutional Ownership

17.7% of Arcadia Biosciences shares are held by institutional investors. 4.5% of Arcadia Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current recommendations for Kirin and Arcadia Biosciences, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kirin	1	0	0	0	1.00
Arcadia Biosciences	1	0	0	0	1.00

Profitability

This table compares Kirin and Arcadia Biosciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Kirin	7.79%	12.29%	5.63%
Arcadia Biosciences	-234.53%	-183.50%	-91.25%

Valuation and Earnings

This table compares Kirin and Arcadia Biosciences”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kirin	$16.28 billion	0.93	$988.53 million	$1.57	11.93
Arcadia Biosciences	$4.75 million	0.24	-$2.34 million	($4.56)	-0.10

Kirin has higher revenue and earnings than Arcadia Biosciences. Arcadia Biosciences is trading at a lower price-to-earnings ratio than Kirin, indicating that it is currently the more affordable of the two stocks.

Summary

Kirin beats Arcadia Biosciences on 8 of the 11 factors compared between the two stocks.

About Kirin

Kirin Holdings Company, Limited engages in food and beverages, pharmaceuticals, and health science businesses. The company's products include beer, wine, whiskey, spirits, soft drinks, dairy products, and other products. It also produces and sells pharmaceutical products, biochemical products, and other products. In addition, the company engages in the factories and theme park businesses; management and operation of a chain of Kirin City beer pubs; and manufacture and sale of amino acids and nucleic acids for pharmaceutical and industrial use bulk pharmaceuticals, as well as margarine, jams, and honey. Further, it is involved in the manufacture and sale of Coca-Cola products and other soft drinks; manufacture of Four Roses bourbon; transport logistic services; shared services, such as accounting, human resources, and real estate; Internal information system development; sales of feed; insurance agent; and sales of the supplements; research, development, manufacture, and sale of cosmetics and health foods. The company was formerly known as Kirin Brewery Company, Limited and changed its name to Kirin Holdings Company, Limited in July 2007. Kirin Holdings Company, Limited was founded in 1885 and is headquartered in Tokyo, Japan.

About Arcadia Biosciences

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.